Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Catalyst Pharm Inc (CPRX)

Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,000,868
  • Shares Outstanding, K 118,115
  • Annual Sales, $ 398,200 K
  • Annual Income, $ 71,410 K
  • 60-Month Beta 0.71
  • Price/Sales 4.96
  • Price/Cash Flow 8.13
  • Price/Book 3.51
Trade CPRX with:

Options Overview Details

View History
  • Implied Volatility 42.50% ( -4.57%)
  • Historical Volatility 28.26%
  • IV Percentile 50%
  • IV Rank 40.08%
  • IV High 77.22% on 07/10/24
  • IV Low 19.27% on 06/17/24
  • Put/Call Vol Ratio 0.02
  • Today's Volume 103
  • Volume Avg (30-Day) 171
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 4,337
  • Open Int (30-Day) 3,939

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.39
  • Number of Estimates 4
  • High Estimate 0.42
  • Low Estimate 0.35
  • Prior Year 0.33
  • Growth Rate Est. (year over year) +18.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.75 +14.85%
on 06/26/24
17.24 -1.71%
on 07/17/24
+1.97 (+13.16%)
since 06/18/24
3-Month
14.47 +17.07%
on 05/09/24
17.24 -1.71%
on 07/17/24
+1.81 (+11.96%)
since 04/19/24
52-Week
11.55 +46.67%
on 10/02/23
17.50 -3.17%
on 03/01/24
+3.37 (+24.83%)
since 07/19/23

Most Recent Stories

More News
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now

These two healthcare stocks may be deeply undervalued.

ETN : 311.89 (+0.91%)
CPRX : 16.94 (+1.32%)
NVAX : 13.85 (-7.42%)
SNY : 50.62 (+0.52%)
3 Biopharma Stocks You Don't Want to Miss in the New Bull Market

All three have exciting programs on the way.

VRTX : 491.57 (+0.71%)
CMPS : 7.30 (+0.41%)
CPRX : 16.94 (+1.32%)
3 Biotech Stocks You Can Buy and Hold for the Next Decade

These companies are still in the early innings of their growth potential.

CPRX : 16.94 (+1.32%)
RXRX : 7.61 (-3.30%)
CRBU : 2.30 (-4.38%)
Forget Shiba Inu: This Stock is Poised for a Potential Bull Run in 2024

With multiple drugs on the market and revenue ramping up, the sky's the limit.

CPRX : 16.94 (+1.32%)
3 Robinhood Stocks to Buy Right Now

The no-cost trading platform's customers have their clear favorites, and they're more mainstream names than you might expect them to be.

AMZN : 183.13 (-0.34%)
CPRX : 16.94 (+1.32%)
ADBE : 551.00 (-1.05%)
2 Robinhood Stocks With Market-Beating Potential

These diamonds in the rough won't stay down.

CPRX : 16.94 (+1.32%)
O : 57.58 (-0.26%)
Down 19% in 1 Day, Is Catalyst Pharmaceuticals a Smart Contrarian Buy?

When evaluating investments, it helps to keep quarterly performance in context.

CPRX : 16.94 (+1.32%)
2 Top Growth Stocks That Can Withstand an Economic Downturn

These two drugmakers should march higher in 2023 and beyond.

CPRX : 16.94 (+1.32%)
LLY : 857.47 (+1.01%)
1 Growth Stock to Buy Before the Next Bull Market

The stock is on a roll, and the company just made a major new purchase.

CPRX : 16.94 (+1.32%)
2 Growth Stocks to Invest $1,000 in Right Now

Both of these biopharmas have major catalysts that are in play or drawing near.

VRTX : 491.57 (+0.71%)
CPRX : 16.94 (+1.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Catalyst Pharmaceuticals, Inc. is a development-stage biopharmaceutical company focused on the development and commercialization of therapies targeting rare neurological diseases and disorders, like Lambert-Eaton Myasthenic Syndrome (LEMS), epilepsy and Tourette syndrome. Catalyst in-licensed rights...

See More

Key Turning Points

3rd Resistance Point 17.41
2nd Resistance Point 17.21
1st Resistance Point 17.08
Last Price 16.94
1st Support Level 16.75
2nd Support Level 16.55
3rd Support Level 16.42

See More

52-Week High 17.50
Last Price 16.94
Fibonacci 61.8% 15.22
Fibonacci 50% 14.52
Fibonacci 38.2% 13.82
52-Week Low 11.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar